• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Non-alcoholic fatty liver disease associated with brain volume loss in middle-aged individuals

byJames EnglandandAnees Daud
December 5, 2017
in Chronic Disease, Gastroenterology, Imaging and Intervention, Neurology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cross-sectional study of middle-aged adults, radiologic evidence of non-alcoholic fatty liver disease (NAFLD) was associated with reduced total cerebral brain volume (TCBV) as measured by MRI.

2. The estimated brain aging linked with NAFLD was greater for younger patients and the association became less significant in older participants.

Evidence Rating Level: 3 (Average)    

Study Rundown: The prevalence of NAFLD is rising world-wide and represents the most common cause of chronic liver disease in older adults. Some studies and animal models have suggested a link between NAFLD and cognitive decline, thought in part to be due to shared risk factors. However, some investigations have suggested a more causal relationship with hepatic inflammation and hepatokine release on adverse brain health. As NAFLD is amenable to lifestyle intervention and may represent a modifiable risk factor, understanding the relationship between NAFLD and brain function is important. The current study is a cross-sectional analysis that explored the relationship between radiographic NAFLD and brain volume as measured by MRI. The study demonstrated that NAFLD was linked to decreased TCBV even after accounting for known covariates. The estimated effect on brain age was greater for younger patients.

The current study provides evidence for a possible connection between NAFLD and brain health that may be more than just shared risk factors.  The study used a population of patients with well-studied cardiovascular parameters and may be important for generating hypotheses for further studies. It is limited by the reliance of radiographic rather than biopsy proven NAFLD or functional cognitive testing, homogenous nature of the population, and cross-sectional design limiting evaluation of causation.

Click to read the study, published in JAMA Neurology

RELATED REPORTS

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

2 Minute Medicine Rewind November 10th, 2025

Relevant Reading: Non-alcoholic fatty liver disease and cerebral small-vessel disease in cognitively normal individuals

In-Depth [cross-sectional study]: This study is a cross-sectional analysis of the offspring cohort of the Framingham Heart Study which evaluated participants between 2002 and 2005. Participants were excluded if they were younger than 35 years (men) or 40 years (women), consumed more than 14 (men) or 7 (women) alcoholic beverages a week, were greater than 160 kgs, had established dementia, or if CT scans of the abdomen, or MRI of the brain were not available.

There were 766 participants included in the study, and 137 (17.9%) had CT evidence of NAFLD. NAFLD was linked to reduced TCBV after adjustment for known covariates (β [SE], –0.26 [0.11]; p = 0.02). Estimated for brain age loss was 7.3 years for participants under 60 years, 4.2 years for those aged 60-74, and 1.5 years for those 75 years of older.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive impairmentdementianon-alcoholic fatty liver disease (NAFLD)
Previous Post

Erenumab linked to decreased episodic migraine frequency: The STRIVE trial

Next Post

Parents report greater optimism than oncologists about their child’s cancer prognosis

RelatedReports

2 Minute Medicine Rewind August 19, 2019
Chronic Disease

Risk of Parkinson’s disease after human papillomavirus infection: a nationwide cohort study

November 13, 2025
Chronic Disease

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study

November 12, 2025
Weekly Rewinds

2 Minute Medicine Rewind November 10th, 2025

November 10, 2025
FDA-regulated clinical trials rarely report violations
The Scan by 2 Minute Medicine®

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

October 22, 2025
Next Post
AAP supports limits on juice consumption in pediatric diet

Parents report greater optimism than oncologists about their child’s cancer prognosis

AAP reaffirms support for adolescents’ rights to confidential reproductive care

Multiple treatment trajectories exist in adolescent depression

Use of plant-based therapies and menopausal symptoms

Clinician denial of certain patient requests linked with decreased satisfaction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
  • Weekly islatravir plus lenacapavir maintains HIV virologic suppression
  • Certain cannabis-based products may offer modest reductions in pain
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.